We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUN icon
26
Cedar Fair
FUN
$1.67B
$23.5M 1.14%
+1,034,288
New +$27.5M
ABM icon
27
ABM Industries
ABM
$2.84B
$23.1M 1.12%
499,838
+231,988
+87% +$11M
IOVA icon
28
Iovance Biotherapeutics
IOVA
$2.87B
$22.9M 1.11%
10,541,608
+2,246,945
+27% +$5.31M
DV icon
29
DoubleVerify
DV
$2.03B
$21.7M 1.05%
+1,808,905
New +$26.8M
ENOV icon
30
Enovis
ENOV
$1.53B
$21.6M 1.05%
712,669
+131,705
+23% +$3.99M
LEG icon
31
Leggett & Platt
LEG
$1.31B
$20.8M 1.01%
2,344,306
+717,079
+44% +$6.83M
DOLE icon
32
Dole
DOLE
$1.32B
$20.7M 1%
1,540,959
+301,319
+24% +$4.23M
INGM
33
Ingram Micro Holding
INGM
$6.55B
$20M 0.97%
929,332
+341,895
+58% +$6.94M
CNMD icon
34
CONMED
CNMD
$1.47B
$19.8M 0.96%
+420,003
New +$21.8M
BKH icon
35
Black Hills Corp
BKH
$5.69B
$19.6M 0.95%
+318,356
New +$18.7M
CHRD icon
36
Chord Energy
CHRD
$7.39B
$19.6M 0.95%
197,300
-16,365
-8% -$1.72M
MATV icon
37
Mativ Holdings
MATV
$711M
$19.1M 0.92%
1,688,881
-431,095
-20% -$4.27M
CART icon
38
Maplebear
CART
$11.8B
$17.6M 0.85%
479,404
-83,787
-15% -$3.86M
AIN icon
39
Albany International
AIN
$1.78B
$17.3M 0.84%
+323,995
New +$20.6M
ECVT icon
40
Ecovyst
ECVT
$1.14B
$16.7M 0.81%
+1,909,686
New +$16.8M
OMC icon
41
Omnicom Group
OMC
$23.4B
$16.3M 0.79%
199,906
-15,263
-7% -$1.15M
DMC
42
Del Monte Corp
DMC
$1.45B
$15.7M 0.76%
452,560
-32,790
-7% -$1.16M
ZD icon
43
Ziff Davis
ZD
$1.98B
$15.6M 0.75%
408,449
+188,844
+86% +$6.61M
SEE
44
DELISTED
Sealed Air
SEE
$15.5M 0.75%
438,282
+68,468
+19% +$2.18M
SSTK icon
45
Shutterstock
SSTK
$219M
$15.4M 0.74%
736,851
-53,551
-7% -$1.09M
FVRR icon
46
Fiverr
FVRR
$339M
$15.2M 0.74%
+622,431
New +$15.3M
UHS icon
47
Universal Health Services
UHS
$10.5B
$15M 0.73%
73,266
+46,535
+174% +$8.37M
BPOP icon
48
Popular Inc
BPOP
$11.1B
$15M 0.72%
117,817
-65,151
-36% -$7.79M
PATH icon
49
UiPath
PATH
$7.8B
$14.7M 0.71%
+1,098,139
New +$13M
COP icon
50
ConocoPhillips
COP
$141B
$14.6M 0.71%
154,135
-10,918
-7% -$1.03M
1
2
3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.